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Abstract Supersaturation and rapid nucleation of cholesterol 
in bile are of key importance in the pathogenesis of cholesterol 
gallstones. While the effects of bile acids and phospholipids on 
cholesterol saturation of bile have been extensively studied, their 
influence on the cholesterol nucleation time has not been com- 
pared. We, therefore, investigated whether increases of bile acid 
or phospholipid concentrations in bile by in vitro supplementa- 
tion affect the cholesterol nucleation time. Bile samples were ob- 
tained at surgery from patients with cholesterol gallstones. Prior 
to the nucleation assay the bile samples were divided into 0.5-ml 
aliquots and supplemented with 1.25, 2.5, 5.0, and 10.0 pmol/ml 
of different phosphatidylcholines (PC-dimyristoyl, PC-dipalmitoyl, 
PC-distearoyl, and extracted biliary PCs) or with 5.0, 10.0, and 
20.0 pmollml of bile acids (glycine or taurine conjugates of 
cholic acid, deoxycholic acid, or chenodeoxycholic acid). The in- 
crease of phosphatidylcholine or bile acid Concentration 
decreased the mean cholesterol saturation index to a similar ex- 
tent (PC: 0.1-0.3; BA: 0.1-0.2). Supplementations of bile with 
increasing amounts of synthetic or biliary PCs caused a marked 
prolongation of the nucleation time in bile from 1.5 5 0.2 up to 
2 21 days or 2.5 * 0.7 up to 1 21 days. Concurrently, biliary 
cholesterol was shifted from vesicles to mixed micelles and the 
cholesteroVphospholipid ratio of the remaining vesicles was 
progressively lowered. In contrast, the addition of bile acids to 
gallbladder bile did not affect the cholesterol nucleation time 
(2.2 * 0.3 days), the percentage of vesicular cholesterol, or the 
cholesteroYphospholipid ratio of vesicles and micelles. One 
can speculate from these in vitro studies that increasing phos- 
pholipid concentrations in bile might be more effective for the 
prevention of cholesterol gallstones than increasing bile acid 
concentrations.-Jiingst, D., T. Lang, P. Nuber, V. Lange, 
and G. Paumgartner. Effect of phospholipids and bile acids on 
cholesterol nucleation time and vesicular/miceUar cholesterol in 
gallbladder bile of patients with cholesterol stones. J.  Lipid Res. 
1993. 34: 1457-1464. 
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In gallbladder bile from cholesterol gallstone patients, 
cholesterol crystal formation is accelerated when com- 
pared to equally supersaturated bile from healthy controls 
or patients with pigment stones (1-4). It is thought that 
nucleation of cholesterol monohydrate crystals from both 
model and native biles occurs mainly after fusion and 
aggregation of phospholipid-cholesterol vesicles to form 
birefringent liquid crystalline droplets (5). There seems to 
be a balance in bile between nucleation inhibitors and 
promoters and there is evidence that these may be pro- 
teins (6-8). Phospholipids represent quantitatively the se- 
cond most important lipid fraction in bile and dissolve 
cholesterol in mixed bile acid-phospholipid micelles as 
well as in phospholipid vesicles (9-12). Phosphatidylcho- 
lines are the predominant biliary phospholipids and their 
major molecular species are the least hydrophobic found 
in liver cell membranes (13). Seventy to 80% of phos- 
phatidylcholines in bile are sn-1 palmitoyl (16:O) with 
either sn-2 oleoyl (18:l) or linoleoyl (18:2) fatty acids (14, 
15). Thus, particular molecular species of phosphatidyl- 
cholines are preferentially solubilized in bile salt micelles 
(16). Changes in the pattern of fatty acids of biliary phos- 
phatidylcholines with an increase of arachidonic acid have 
been observed in bile from patients with cholecystolithia- 
sis (17). In a recent study Nervi et al. (18) have indicated 
that an apparently selective reduction in biliary phos- 
pholipids by nutritional factors may be responsible for the 
high prevalence of cholesterol gallstones in certain popu- 
lations. In many other previous studies, such a selective 
reduction in phospholipid concentration has not been im- 
plicated as a cause of cholesterol gallstone disease (19, 20). 
We were stimulated by the findings of Nervi et al. (18) to 
investigate whether an increase of biliary phospholipid 
Abbreviations: CSI, cholesterol saturation index; CH, cholesterol; 
PC, phosphatidylcholine; PL, phospholipid; BA, bile acids; C, cholic 
acid; CDC, chenodeoxycholic acid; DC, deoxycholic acid; UDCA, ur- 
sodeoxycholic acid; TLC, thin-layer chromatography; IMC, intermicel- 
lar concentration. 
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concentrations by in vitro supplementation would 
prolong the abnormally rapid nucleation of cholesterol in 
the gallbladder bile of patients with cholesterol gallstones. 
Three synthetic molecular species of saturated phos- 
phatidylcholines with different patterns of fatty acids and 
phosphatidylcholines extracted from human gallbladder 
bile of patients with cholesterol or pigment stones were 
used for the supplementation experiments. In control ex- 
periments we investigated the effect of an increase of bile 
acid concentrations on the cholesterol nucleation time by 
adding taurine or glycine conjugates of cholic, deoxy- 
cholic, and chenodeoxycholic acid to bile. 
MATERIALS AND METHODS 
Patients and collection of biles 
Fifty-two patients, 37 women and 15 men who under- 
went elective surgery because of symptomatic gallstone 
disease, were selected for the study. Gallbladder bile was 
aspirated with an 18-gauge needle by puncture of the gall- 
bladder during surgery within 3 min after ligation of the 
cystic duct. Particular care was taken to collect gallblad- 
der bile completely, because of the possibility of stratifica- 
tion (21) and to avoid disruption of the mucosa by clamp- 
ing of the gallbladder wall prior to this procedure. The 
stones were removed with the gallbladder, washed with 
distilled water, dried, and weighed. The cholesterol con- 
tent was measured chemically after extraction with or- 
ganic solvents and expressed as percentage of the dry 
weight (22). 
Microscopy of bile and nucleation time 
After collection, bile samples were mixed thoroughly 
and one drop was immediately examined by polarized 
light microscopy for cholesterol crystals. Cholesterol 
nucleation time was determined as described recently (23) 
with a slight modification of the original method of Holan 
et al. (1). 
Analysis of biliary lipids 
For the analysis of bile lipids, duplicate aliquots were 
stored at - 7OoC prior to determination. Cholesterol was 
determined colorimetrically by the Liebermann- 
Burchard reaction after double extraction of 1 ml metha- 
nolic bile sample with petroleum ether (24). Phos- 
pholipids were measured as total biliary phosphate after 
hydrolysis at 150°C with sulfuric acid, using the colori- 
metric assay of Fiske-SubbaRow (25). Inorganic phos- 
phate contributes only minor amounts to total biliary 
phosphate; therefore, total phosphate adequately reflects 
lipid-bound phosphate. Total bile salts were determined 
by a modified Sa-hydroxysteroid dehydrogenase method 
(26). The saturation index of each sample was calculated 
by dividing the cholesterol concentration by the maxi- 
mum cholesterol solubility according to Carey (27) and 
corrected for the total lipid content of each individual bile. 
Separation of vesicles and micelles 
Micelles were separated from vesicles by gel filtration as 
described by Somjen and Gilat (11). Glass columns (30 x 
1.2 cm) were filled with Sephacryl-S-300 superfine gel 
containing 0.04% sodium azide in distilled water (Phar- 
macia AB, Uppsala, Sweden). The void volume of the 
column was determined with 2% Dextran Blue 2000 
(Pharmacia). After ultracentrifugation (100,000 g for 1 h) 
of the bile, 0.5 ml of the isotropic phase was applied to the 
column and eluted in 1.2-ml fractions using Tris-HC1 
buffer (pH 8.0) containing 10 mM sodium cholate to pre- 
vent disruption of micellar lipids. Thirty-five fractions 
were collected and analyzed for cholesterol and phos- 
pholipid content. One hour after supplementation of bile 
with the respective amounts of PC or BA aliquots, 0.5 ml 
was processed as described above, without further 
ultracentrifugation prior to the column chromatography. 
Supplementation experiments 
Synthetic crystalline L-a-phosphatidylcholinedimyristoyl 
(P-6392), L-a-phosphatidylcholinedipalmitoyl (P-1652), 
and L-a-phosphatidylcholinedistearoyl (P-6517) were ob- 
tained from Sigma (St. Louis, MO). Biliary phos- 
pholipids were extracted from gallbladder bile (chloro- 
form-methanol 2:1, v/v) and fractionated by TLC on 20 
x 20 cm glass plates coated with silica gel (Merck). After 
one-dimensional TLC in the solvent system (chloro- 
form-methanol-25% aq. ammonia, 60:20:5) the sepa- 
rated PCs were made visible with iodine vapor, recovered, 
and assayed for phosphorus content. Prior to the nuclea- 
tion assay, bile samples were divided into 0.5-ml aliquots 
and supplemented with 1.25, 2.5, 5.0, and 10.0 pmol/ml 
of the different types of PCs. For supplementation the PCs 
were dissolved in methanol (50 pmol/ml) and the respec- 
tive amounts were pipetted into the test tubes, dried with 
a stream of NZ, and redissolved in the bile aliquots. Com- 
plete dissolution was achieved after 1 h as documented by 
the determination of phospholipid concentration in each 
sample. After 1 h, samples of the bile were taken for 
nucleation studies and chromatographic separation. 
Sodium salts of taurocholic acid (T-4009), taurocheno- 
deoxycholic acid (T-6260), taurodeoxycholic acid (T-0875), 
glycocholic acid (G-2878), glycochenodeoxycholic acid 
(G-0759), and glycodeoxycholic acid (G-6132) were ob- 
tained from Sigma (St. Louis, MO). These bile acids were 
dissolved in methanol (100 pmol/ml) and 2.5, 5.0, and 
10.0 pmol were pipetted into the test tubes. After drying 
with a stream of NZ, bile acids were redissolved in 0.5-ml 
bile aliquots. Complete dissolution was assessed after 1 h 
by measurement of bile acid concentration in each sam- 
ple. After 1 h, samples of the bile were taken for nuclea- 
tion studies and chromatographic separation. 
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Statistical analysis Days 
20 - Data are expressed as means f SEM. Means between 
groups were compared using Student’s t test for paramet- 
ric data and Wilcoxon’s rank test and Mann-Whitney test 
for non-parametric data (nucleation time). A P value < 
0.05 was considered statistically significant. 
E .- + ‘0 15- 
.- c 
cp 
Q, 
z 
-5 10- 
RESULTS - 
i 
c 5 -  Stone analysis and biliary microscopy 
v) 
0)  
0 
-The cholesterol content of the stones ranged from 53 to 
1 
1.25 2.5 5.0 10.0 
PC-Supplementation (umol/ml) 
96% (mean 69 * 2.2%). Biliary microscopy showed typi- 
cal cholesterol crystals in all native biles as well as in the 
sediment after ultracentrifugation. 
Lipid analysis, cholesterol saturation and nucleation 
Fig. 1. Effect of bile supplementation with L-a-PC-dimyristoyl (C 
14:O). L-a-PC-dipalmitoyl (C 16:0), and L-a-PC-distearoyl (C 18:O) on time . .  
M~~~ values SEM for lipids, CSI, and cholesterol cholesterol nudeation time in gallbladder biles of 15 -patients with 
cholesterol gallstones. 
nucleation time in the bile samples used for the different 
supplementation experiments are given in Table 1. 
Supplementation experiments 
After addition of the PCs, the calculated CSI declined 
from 1.6 * 0.3 to 1.5 f 0.2 with the minimum amount 
of PC supplementation (1.25 pmol/ml bile) and reached 
the lowest value of 1.3 * 0.2 when the maximum amount 
of PCs (10.0 pmollml bile) was added. A marked prolon- 
gation of the cholesterol nucleation time was achieved in 
all bile samples after the supplementation with all types 
of PCs (Fig. 1). PC-dipalmitoyl and PC-distearoyl were 
more effective than PC-dimyristoyl (Fig. 1). Even when 
only low amounts of PC-dipalmitoyl or PC-distearoyl 
(1.25 pmol/ml bile) were added, a considerable prolonga- 
tion of the cholesterol nucleation times from 1.5 * 0.2 
days to 6.5 * 2.1 days and 7.5 + 2.4 days, respectively, 
was seen. After supplementation with higher amounts of 
both PCs, no cholesterol crystals were observed during 
the observation period of 21 days, despite the fact that the 
biles were still supersaturated (CSI > 1.0) in the majority 
of the samples. 
Similarily, supplementation with increasing amounts of 
extracted biliary phosphatidylcholines from patients with 
cholesterol or pigment stones progressively prolonged the 
nucleation time from 2.5 f 0.7 to > 21 days (Fig. 2). 
Concurrently, the percentage of total biliary cholesterol in 
vesicles decreased from 20.2 f 3.2% to 5.1 * 2.6% and 
the cholesterol/phospholipid ratio of the remaining vesi- 
cles was progressively lowered from 1.3 * 0.1 to 0.4 * 0.1 
(Fig. 3). 
The addition of single taurine or glycine conjugates of 
chenodeoxycholic acid, deoxycholic acid, or cholic acid lo- 
wered the CSI from 1.7 * 0.2 to 1.6 * 0.2, 1.6 * 0.2, 
and 1.5 + 0.2 when the respective amounts of 5.0, 10.0, 
and 20.0 pmol/ml bile were added. However, supplemen- 
tation of bile with these different bile acids did not affect 
TABLE 1. Concentrations of bile acids, phospholipids, cholesterol, and total lipids, cholesterol saturation index, and cholesterol nucleation 
time of gallbladder biles for phospholipid and bile acid supplementation experiments 
Supplementation with 
Supplementation with mixtures of glycine: 
Supplementation with Supplementation with single glycine or taurine ( 3 : l )  conjugates 
PC-dimyristoyl, PC-dipalmitoyl, extracted biliary taurine conjugates of of CDC (38%), 
Variable or PC-distearoyl (n - 15) PCs (n=12) CDC, DC, or C (n = 15) DC (la%), or C (44%) (n = 10) 
Bile acids (mmoV1) 72.0 f 8.0 71.1 f 10.1 65.2 f 8.5 
Phospholipids (mmolfl) 26.0 f 2.7 18.7 f 2.2 23.0 f 2.8 
9.6 f 1.2 9.1 f 1.2 
CSI 1.6 f 0.2 1 . 7  f 0.2 1.7 f 0.2 
Total lipids (g/dl) 5.9 f 0.6 5.3 f 0.6 5.3 f 0.6 
Nudeation time (days) 1.5 f 0.2 2.5 f 0.7 2.2 + 0.3 
Cholesterol (mmolfl) 10.0 f 0.9  
84.8 f 14.5 
33.9 f 5.4 
10.9 f 2.3 
1.2 f 0.1 
7.2 f 1 . 1  
2.0 f 0.5  
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Fig. 2. Effect of bile supplementation with extracted phosphatidylcho- 
lines from gallbladder bile of patients with cholesterol (0) or pigment 
(0) stones on cholesterol nucleation time in gallbladder biles of 12 pa- 
tients with cholesterol gallstones. 
the cholesterol nucleation time (2.2 f 0.3 days) 
significantly (Fig. 4). In additional experiments the effect 
of bile acids on vesicular/micellar cholesterol in gallblad- 
der bile of patients with cholesterol stones was investigated. 
Ten gallbladder biles were supplemented with a mix- 
ture (3:l) of glycinehaurine conjugates of cholic (44%), 
chenodeoxycholic (38%), and deoxycholic (18%) acid. As 
expected from the previous experiments, the addition of 
this bile acid mixture (5.0, 10.0, and 20.0 Fmol/ml bile) 
did not affect the cholesterol nucleation time (2.0 0.5 
days). Furthermore, the percentage of total biliary 
cholesterol in vesicles (25.5 4.1%) or the cholesterol/ 
phospholipid ratio in vesicles (0.7 f 0.1) did not change 
(Fig. 5).  
DISCUSSION 
Phosphatidylcholine is the predominant phospholipid 
in bile and has a major role in the solubilization and 
transport of biliary cholesterol. Although the bile acids 
are generally recognized as the principal solubilizing 
agents in bile, their capacity to render cholesterol soluble 
in bile is severely reduced in the absence of phospholipids 
(28). The supplementation experiments of this study us- 
ing pure synthetic crystalline disaturated phosphatidyl- 
cholines showed that the addition of increasing doses to 
human biles progressively prolonged the nucleation time. 
Slight differences in the antinucleatory effect of these 
phosphatidylcholines might be related to the different 
length of the fatty acid chains. It has to be noted that the 
completely saturated phosphatidylcholines used for sup- 
plementation in the study do not occur physiologically in 
bile. Therefore, additional studies in gallbladder biles 
from patients with cholesterol gallstones using extracted 
phosphatidylcholines from human gallbladder bile were 
performed. These supplementation experiments showed a 
comparable increase of the cholesterol nucleation time as 
in the studies using synthetic disaturated phosphatidyl- 
cholines. Moreover, phosphatidylcholines extracted from 
bile from patients with cholesterol stones seemed to be as 
effective as phosphatidylcholines extracted from bile from 
patients with pigment stones. However, gallbladder bile 
phosphatidylcholines were recovered after iodine visaliza- 
tion of the chromatography plates. Iodination occurs 
across double bonds and may lead to a relative decrease 
in polyunsaturated fatty acids with a proportional in- 
crease in more saturated fatty acids (29). Subjects with 
cholesterol gallstones were reported to have alterations in 
the molecular species of PC in bile, although the results 
of various studies are conflicting (15, 17, 30-32). There- 
fore, our findings do not exclude that a different pattern 
of the molecular species of PC in bile is responsible for the 
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Fig. 3. Effect of bile supplementation with extracted phosphatidylcho- 
lines from gallbladder bile on the percentage of total biliary cholesterol 
in vesicles and cholesterol/phospholipid ratio in vesicles (0) and micelles 
(0) in gallbladder biles of 12 patients with cholesterol gallstones. 
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Fig. 4. Effect of bile supplementation with single glycine (0) or tau- 
rine (0) conjugates of cholic, chenodeoxycholic, and deoxycholic acid on 
cholesterol nucleation time in gallbladder biles of 15 patients with 
cholesterol gallstones. 
more rapid nucleation of cholesterol in gallbladder bile of 
patients with cholesterol stones compared to biles from 
patients with pigment stones. 
Several studies suggest that cholesterol crystals in bile 
derive mainly from cholesterol-rich phospholipid vesicles 
(5, 33) and a close association of crystals and these vesicles 
has been reported (34). The addition of phosphatidylcho- 
lines to bile might stabilize these vesicles and enhance 
their capacity to transport cholesterol. In our study even 
small amounts (1.25 pmol/ml) of added PCs prolonged 
cholesterol nucleation significantly. A decrease of the 
CH/PL ratio in isolated vesicles was observed which 
might be responsible for the increased cholesterol nuclea- 
tion time. Furthermore, our experiments demonstrate a 
shift of biliary cholesterol from the less stable vesicular 
phase to the more stable mixed micellar phase after the 
addition of increasing doses of phospholipids extracted 
from gallbladder bile. Thus, the observed prolongation 
and normalization of the cholesterol nucleation time after 
adding these phosphatidylcholines might be caused by 
both a phase transition of biliary cholesterol and a 
decreased CH/PL ratio in the remaining vesicles. 
Kibe et al. (35) have studied extensively factors affect- 
ing cholesterol monohydrate crystal nucleation time in 
model systems of supersaturated bile. Increasing the 
degree of cholesterol supersaturation as an independent 
variable shortened the nucleation time in concentrated 
but not in dilute systems. A decrease in bile BA/PL molar 
ratio within the physiologically relevant range from 4.0 to 
2.0 was accompanied by a prolonged nucleation time and 
favored spontaneous vesicle formation. 
Phospholipid supplementation in our study decreased 
the BA/PL molar ratio from 2.8 to 2.0 within the physio- 
logically relevant range, prolonged nucleation time but 
did not favor vesicle formation. In contrast to the study of 
Kibe et al. (35), a significant decrease of vesicular 
cholesterol was observed particularly in biles sup- 
plemented with higher doses of PC (5-10 pmol/ml). The 
reason for this discrepancy is unclear but demonstrates 
that observations in model biles may not be relevant for 
human biles. 
T 
20 56 
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Fig. 5. Effect of bile supplementation with a mixture of glycinehaurine 
(3:l) conjugates of cholic (44%), chenodeoxycholic (38%), and deoxy- 
cholic (18%) acid on the percentage of total biliary cholesterol in vesicles 
and cholesterol/phospholipid ratio in vesicles (0) and micelles (0) in 
gallbladder biles of 10 patients with cholesterol gallstones. 
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The effect of phospholipids and their molecular species 
on cholesterol solubility and nucleation in human and 
model biles has been studied recently by Halpern et al. 
(36). In agreement with our results they found that the 
addition of egg phosphatidylcholine to human biles 
prolongs the nucleation time, shifts cholesterol from the 
vesicular phase to the non-vesicular phase, and reduces 
the CH/PL ratio of the remaining vesicles. Donovan, 
Timofeyeva, and Carey (37) have monitored the forma- 
tion of liquid crystals and cholesterol monohydrate crys- 
tals in supersaturated model biles (10% total lipid) at 
comparable cholesterol saturation indices for various egg 
yolk PC/BA ratios (0, 0.25, 0.67). For fixed PC/BA ratios 
and CSI, cholesterol nucleation times increased at high 
PC/BA ratios. Therefore, several studies in human or 
model biles demonstrate a beneficial effect of increasing 
PC concentrations on biliary lithogenicity. 
Furthermore, Cohen and Carey (38) have shown that 
acyl chain unsaturation modulates distribution of lecithin 
molecular species between mixed micelles and vesicles in 
model bile. Vesicles were enriched with lecithins contain- 
ing the most saturated sn-1 or sn-2 chains by as much as 
2.4-fold whereas mixed micelles were enriched with the 
more unsaturated lecithins. They suggest that modifica- 
tions of biliary lecithins species may profoundly influence 
the physical chemistry of native bile as well as gallstone 
formation and prevention. Similar results have been 
reported more recently by Booker et al. (39) for human 
gallbladder bile. As in our study, biles were fractionated 
by Sephacryl S-300 SF gel filtration chromatography, and 
a sodium cholate concentration of 10 mM was chosen for 
all chromatographic separation of lipid particles. Gel 
filtration is capable of providing separation of discrete 
populations of micelles and vesicles, but the procedure 
may not ensure the integrity of each (40). If the correct 
IMC of BA were present in the eluant buffer and assum- 
ing there is no interaction between the column matrix and 
BA, then micelles and vesicles of native biles could be 
separated without alterations in the size or the composi- 
tion of each phase. Donovan, Timofeyeva, and Carey (41) 
have studied the influence of total lipid concentration, bile 
sa1t:lecithin ratio, and cholesterol content on inter-mixed 
micellar/vesicular (non-lecithin-associated) BA concen- 
trations in model bile. They concluded that by using an 
eluant containing 10 mM sodium cholate, separation of 
vesicles and micelles from model biles with total lipid con- 
centrations similar to gallbladder bile may overestimate 
the proportion of vesicular lipids. Therefore, it appears 
that, in absolute terms, an accurate assessment of 
cholesterol transport in terms of a micel1e:vesicle ratio for 
a given system is difficult. However, if experimental con- 
ditions are kept constant for the same study, micellexesi- 
cle ratios are reasonably accurate in relative terms (42). 
This seems to be particularly relevant for our study where 
changes of the micel1e:vesicle ratios are determined before 
and after PC or BA supplementation in different aliquots 
from one original gallbladder bile. 
One can speculate from these in vitro studies that in- 
creasing phosphatidylcholine concentration in bile might 
be a promising approach in preventing cholesterol gall- 
stone disease. However, we must consider that our in vitro 
experiments might be quite unphysiological. As we know 
from Gallinger et al. (43) and Pattinson and Willis (44) 
ultracentrifugation of bile samples prior to the nucleation 
assay to remove cholesterol monohydrate crystals does 
reduce considerably the amount of mucin in the remain- 
ing isotropic phase. Mucin is considered as a potent 
nucleation factor (45) and its partial reduction in the bile 
samples by ultracentrifugation might affect the results of 
our study. Furthermore, phospholipids do not enter bile 
from a thin film applied to a surface but are most likely 
secreted in vesicular form (46, 47). Micellar cholesterol is 
solubilized in the phospholipid bilayer of the mixed 
micelles and if phospholipid is secreted in vesicles, then it 
must be transferred to micelles. It seems entirely possible 
that provision of a thin film of phospholipids might permit 
transfer of these lipids mostly or exclusively to micelles 
and thus produce very beneficial micelles in respect to 
cholesterol transport. However, such a selective enrich- 
ment of micelles with phospholipids has not been ob- 
served in our study. The CH/PL ratio in mixed micelles 
remained rather constant (0.26-0.31) in our PC- 
supplementation experiments with a nonsignificant trend 
to increase as a result of dissolving CH/PL vesicles with 
higher CH/PL ratio. In fact, our results demonstrate that 
PCs provided as a thin film on the surface of the test tube 
are incorporated in the vesicles, which results in a marked 
decrease from 1.3 to 0.4 of their CH/PL ratio. 
An antinucleating effect such as that demonstrated 
with phosphatidylcholine could not be observed after the 
addition of different molecular species of bile salts. These 
were added as physiologically occurring sodium salts of 
glycine or taurine conjugates of cholic acid, deoxycholic 
acid, or chenodeoxycholic acid. At a decrease of saturation 
of bile comparable to that in the phospholipid experiments, 
no effect on the cholesterol nucleation time was observed. 
To investigate why addition of bile acids did not in- 
crease nucleation time, a mixture of physiologically oc- 
curring sodium salts of g1ycine:taurine (3:l) conjugates of 
cholic acid, deoxycholic acid, and chenodeoxycholic acid 
was added to the bile samples and the distribution and 
composition of vesicles and mixed micelles in bile were 
studied. No dissolution of phospholipid-cholesterol vesi- 
cles was observed when up to 20 pmol/ml bile acids was 
added and the cholesterol-phospholipid ratio in vesicles 
and micelles did not change significantly in these experi- 
ments. These results could explain why cholesterol nucle- 
ation time in human biles was not affected by supplemen- 
tation of different bile acids in amounts from 5-20 
pmol/ml bile. 
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Donovan et al. (37) have studied the effects of bile salt 
hydrophobicity on cholesterol nucleation in model biles. 
For fixed PC/BA concentration, cholesterol nucleation 
time increased with the hydrophilicity of the bile salts: 
tauroursodeoxycholic acid > taurocholic acid and 
taurodeoxycholic acid. The authors concluded that in- 
creasing bile salt hydrophobicity promotes cholesterol 
crystal formation and hydrophilic bile salts retard nuclea- 
tion of cholesterol. 
In our study, supplementation of bile with glycine or 
taurine conjugates of chenodeoxycholic acid, deoxycholic 
acid, or cholic acid had no significant effect on formation 
of cholesterol crystals. The effect of the hydrophilic bile 
acid ursodeoxycholic acid was not investigated in our 
study because of its physiologically low amounts in hu- 
man bile. However, it has been demonstrated recently in 
several independent studies that oral administration of 
ursodeoxycholic acid prolongs nucleation time in human 
gallbladder bile (48-51). In all these studies a higher 
PL/CH ratio in gallbladder bile was found in UDCA- 
treated patients compared to untreated controls. This 
may be a further mechanism besides the observed abso- 
lute increase of UDCA in bile that could be responsible 
for the retarded nucleation of cholesterol. Similarly, oral 
administration of chenodeoxycholic acid to patients with 
gallstones prolongs cholesterol nucleation time and in- 
creases PL/CH ratio in bile (50-52). 
We conclude that the addition of different phos- 
phatidylcholines including extracted mixtures from hu- 
man gallbladder bile but not physiologically occurring 
bile acids to bile in amounts that comparably decrease the 
CSI prolong the cholesterol nucleation time. This is 
caused by both a phase transition of cholesterol from vesi- 
cles to mixed micelles and a decreased cholesterol phos- 
pholipid ratio of the remaining vesicles. One can specu- 
late from these in vitro studies that increasing phospholipid 
concentrations in bile might be more effective for the 
prevention of cholesterol gallstones than increasing bile 
acid concentrations. I 
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